{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:11:26Z","timestamp":1791983486642,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejradiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ejrad.2020.108813","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T04:09:39Z","timestamp":1578370179000},"page":"108813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer"],"prefix":"10.1016","volume":"124","author":[{"given":"Eralda","family":"Mema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-6826","authenticated-orcid":false,"given":"Jennifer","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-209X","authenticated-orcid":false,"given":"Elianna","family":"Kaplowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goodgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejrad.2020.108813_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-015-3859-y","article-title":"An overview of triple-negative breast cancer","volume":"293","author":"Kumar","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"issue":"11","key":"10.1016\/j.ejrad.2020.108813_bib0010","first-page":"1233","article-title":"Understanding and treating triple-negative breast cancer","volume":"22","author":"Anders","year":"2008","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","article-title":"Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design","volume":"9","author":"Kassam","year":"2009","journal-title":"Clin. Breast Cancer"},{"issue":"6","key":"10.1016\/j.ejrad.2020.108813_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/tbj.12182","article-title":"MR imaging features of triple-negative breast cancers","volume":"19","author":"Sung","year":"2013","journal-title":"Breast J."},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1148\/radiol.2503081054","article-title":"Triple-negative breast cancer: correlation between MR imaging and pathologic findings","volume":"250","author":"Uematsu","year":"2009","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ejrad.2020.108813_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-016-0750-0","article-title":"Mammographic density and breast cancer risk: a mediation analysis","volume":"18","author":"Rice","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"Suppl 8","key":"10.1016\/j.ejrad.2020.108813_bib0045","doi-asserted-by":"crossref","first-page":"viii37","DOI":"10.1093\/annonc\/mdt310","article-title":"Mammographic density, MRI background parenchymal enhancement and breast cancer risk","volume":"24","author":"Pike","year":"2013","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.ejrad.2020.108813_bib0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.clinimag.2015.08.001","article-title":"The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer","volume":"39","author":"Albert","year":"2015","journal-title":"Clin. Imaging"},{"key":"10.1016\/j.ejrad.2020.108813_bib0055","series-title":"ACR BI-RADS\u00ae Mammography. In: ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System","author":"Sickles","year":"2013"},{"key":"10.1016\/j.ejrad.2020.108813_bib0060","series-title":"ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting And Data System","author":"D\u2019Orsi","year":"2013"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.ejrad.2020.108813_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinimag.2017.10.016","article-title":"Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC)","volume":"49","author":"Angelini","year":"2018","journal-title":"Clin. Imaging"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0075","doi-asserted-by":"crossref","first-page":"e0191399","DOI":"10.1371\/journal.pone.0191399","article-title":"The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers","volume":"13","author":"Vreemann","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0080","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/jmri.25798","article-title":"Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis","volume":"47","author":"Mema","year":"2018","journal-title":"J. Magn. Reson. Imaging"},{"issue":"4","key":"10.1016\/j.ejrad.2020.108813_bib0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1148\/rg.2018180035","article-title":"Hormonal effects on breast density, fibroglandular tissue, and background parenchymal enhancement","volume":"38","author":"Heller","year":"2018","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1148\/radiology.203.1.9122383","article-title":"Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast","volume":"203","author":"Muller-Schimpfle","year":"1997","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ejrad.2020.108813_bib0095","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ijc.31370","article-title":"MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women","volume":"143","author":"Brooks","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0100","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2214\/AJR.13.12146","article-title":"Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy","volume":"204","author":"DeLeo","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.ejrad.2020.108813_bib0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.ejrad.2020.108813_bib0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6","article-title":"Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy","volume":"81","author":"Magnusson","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"9084","key":"10.1016\/j.ejrad.2020.108813_bib0120","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer","volume":"350","author":"Calle","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejrad.2020.108813_bib0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.ejrad.2020.108813_bib0130","first-page":"21454","article-title":"Does estrogen receptor determination affect prognosis in early stage breast cancers?","volume":"8","author":"Bulut","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0135","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiol.15142192","article-title":"Association between parenchymal enhancement of the contralateral breast in dynamic contrast-enhanced MR imaging and outcome of patients with unilateral invasive breast Cancer","volume":"276","author":"van der Velden","year":"2015","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.ejrad.2020.108813_bib0140","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1245\/s10434-014-4279-0","article-title":"The 2014 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: triple-negative breast cancer","volume":"22","author":"Newman","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"63","key":"10.1016\/j.ejrad.2020.108813_bib0145","article-title":"Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction","volume":"13","author":"Vogel","year":"2015","journal-title":"BMC Med."},{"issue":"23","key":"10.1016\/j.ejrad.2020.108813_bib0150","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1470-2045(14)71171-4","article-title":"Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial","volume":"16","author":"Cuzick","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ejrad.2020.108813_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mri.2012.06.022","article-title":"Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women","volume":"31","author":"Clendenen","year":"2013","journal-title":"Magn. Reson. Imaging"}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20300024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X20300024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:15:46Z","timestamp":1759994146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X20300024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":32,"alternative-id":["S0720048X20300024"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.108813","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship of breast density in mammography and magnetic resonance imaging in women with triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2020.108813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108813"}}